MELAINE W WALLACE

Allopathic & Osteopathic Physicians|Internal Medicine TUPELO, MS NPI 1346207222

General Payments — all program years on this page

$2,899.21

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 215
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $309.81 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $309.8119

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $806.1371
2019 $316.2726
2020 $140.7710
2021 $189.9014
2022 $615.7140
2023 $520.6235
2024 $309.8119

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087436254 Novartis Pharmaceuticals Corporation $18.56 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087436258 Novartis Pharmaceuticals Corporation $17.50 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101560700 E.R. Squibb & Sons, L.L.C. $14.19 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116199531 Amgen Inc. $14.57 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116199536 Amgen Inc. $16.04 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117971281 Boehringer Ingelheim Pharmaceuticals, Inc. $14.73 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117971283 Boehringer Ingelheim Pharmaceuticals, Inc. $18.43 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117971285 Boehringer Ingelheim Pharmaceuticals, Inc. $21.95 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1129459326 Esperion Therapeutics, Inc. $16.26 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131079905 PFIZER INC. $17.66 02/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131234299 PFIZER INC. $14.26 04/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135187837 Lilly USA, LLC $18.55 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135187839 Lilly USA, LLC $13.12 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135187841 Lilly USA, LLC $17.38 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135208249 Lilly USA, LLC $16.36 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135208253 Lilly USA, LLC $18.55 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135208257 Lilly USA, LLC $13.94 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151137405 Phathom Pharmaceuticals, Inc. $13.62 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151137407 Phathom Pharmaceuticals, Inc. $14.14 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.